---
title: "Whitepaper: Using patient-specific cells for disease modelling"
description: Whitepaper - Using patient-specific cells for disease modelling
image: https://info.edifydigitalmedia.com/hubfs/CMP%20images/Sartorius%20CMP%20-%2028.02.24/Sartorius%20Asset%20Image%20-%2028.02.24.jpg
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![Sartorius Landing Page Banner - 28.02.24](https://info.edifydigitalmedia.com/hs-fs/hubfs/CMP%20images/Sartorius%20Landing%20Page%20Banner%20-%2028.02.24.jpg?width=2000&height=561&name=Sartorius%20Landing%20Page%20Banner%20-%2028.02.24.jpg "Sartorius Landing Page Banner - 28.02.24")

# Whitepaper

# Using patient-specific cells for disease modelling

 

![Sartorius Asset Image - 28.02.24](https://info.edifydigitalmedia.com/hubfs/CMP%20images/Sartorius%20Asset%20Image%20-%2028.02.24.jpg "Sartorius Asset Image - 28.02.24")

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages.

 

Download the Whitepaper to:

- Explore iPSC-derived motor neuron morphology
- Discover how ALS disease phenotype is observed in microglia phagocytosis
- Understand whether both microglia and motor neurons from ALS patients could drive a more pronounced disease phenotype

 *Brought to you by* 

![Sartorius-Logo-RGB-300dpi](https://info.edifydigitalmedia.com/hs-fs/hubfs/CMP%20images/Sartorius-Logo-RGB-300dpi.jpg?width=121&height=46&name=Sartorius-Logo-RGB-300dpi.jpg)

 

### Download Whitepaper

## Copyright 2024 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions